Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs10519497 | chr5:116553829 | C/G | 1.9E-13 | 131 | 46.3 | 28.8 | 17.1 | KM Plot |
| TGCT | rs10544049 | chr19:38000517 | AAAT/A | 1.39E-13 | 134 | 46.3 | 35.37 | 17.1 | KM Plot |
| TGCT | rs10590409 | chr17:32814920 | AGCT/A | 0.000126 | 129 | 24.27 | 60.73 | 37.5 | KM Plot |
| TGCT | rs10626710 | chr12:107089023 | C/CAG | 0.000103 | 134 | 42.27 | 45.47 | 28.8 | KM Plot |
| TGCT | rs1073261 | chr12:107135942 | A/G | 0.000113 | 133 | 42.27 | 45.1 | 28.8 | KM Plot |
| TGCT | rs10746063 | chr12:107086240 | G/T | 5.07E-5 | 134 | 46.77 | 45.1 | 28.67 | KM Plot |
| TGCT | rs10746064 | chr12:107086245 | G/T | 5.07E-5 | 134 | 46.77 | 45.1 | 28.67 | KM Plot |
| TGCT | rs10746067 | chr12:107180069 | A/G | 0.000113 | 133 | 46.77 | 45.1 | 28.8 | KM Plot |
| TGCT | rs1075601 | chr5:167811556 | A/T | 6.08E-5 | 134 | 42.1 | 37.95 | 53.1 | KM Plot |
| TGCT | rs10760515 | chr9:130690412 | G/C | 2.03E-5 | 131 | 118.52 | 46.77 | 41.27 | KM Plot |
| TGCT | rs10773578 | chr12:129290026 | G/C | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |
| TGCT | rs10773762 | chr12:130765366 | C/T | 0.000116 | 134 | 46.77 | 33.53 | 35.67 | KM Plot |
| TGCT | rs10775302 | chr16:67792439 | C/T | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs10778497 | chr12:107027908 | C/G | 3.36E-8 | 134 | 27.93 | 37.75 | 50.97 | KM Plot |
| TGCT | rs10778498 | chr12:107063340 | C/A | 0.000103 | 134 | 48.87 | 38.2 | 28.8 | KM Plot |